Related Experiment Videos

Soluble intercellular cell adhesion molecule-1 and L-selectin plasma concentrations and response to surfactant in

Petra S Koehne1, Mathias H Wagner, Carsten Willam

  • 1Department of Neonatology, Charité Virchow-Hospital, Humboldt University, Berlin, Germany.

Insights

Elevated intercellular cell adhesion molecule (ICAM)-1 at 24 hours indicates a poor response to surfactant in preterm infants. Low L-selectin levels at 24 hours predict the need for prolonged oxygen support.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Biomarkers in Neonatal Care

Background:

  • Preterm infants often suffer from respiratory distress syndrome (RDS).
  • Exogenous surfactant therapy is a standard treatment for RDS.
  • Predicting treatment response and long-term outcomes is crucial for optimizing care.

Purpose of the Study:

  • To determine if plasma levels of soluble intercellular cell adhesion molecule (ICAM)-1 and L-selectin at 24 hours of life correlate with surfactant response in preterm infants.
  • To identify potential biomarkers for predicting treatment outcomes in neonatal respiratory distress.

Main Methods:

  • A prospective study was conducted in a Level III neonatal intensive care unit.
  • Plasma samples were collected at 24 hours of life from 29 preterm infants with severe RDS and 17 healthy preterm controls.
  • Infants with RDS received natural surfactant, and response was defined by a >50% decrease in FiO2 within 6 hours.

Main Results:

  • Elevated ICAM-1 concentrations at 24 hours were significantly associated with a poor response to surfactant therapy (p <.001).
  • Plasma L-selectin levels were lower in surfactant-treated infants compared to controls (p =.004).
  • Reduced L-selectin at 24 hours predicted a prolonged need for supplemental oxygen at 36 weeks gestational age (p =.004).

Conclusions:

  • Elevated circulating ICAM-1 at 24 hours of age is a marker of poor surfactant response in preterm infants with respiratory distress.
  • Low plasma L-selectin levels at 24 hours of age can predict the need for extended supplemental oxygen support.
  • These biomarkers may aid in tailoring respiratory support and predicting outcomes in neonates with RDS.
Abstract

Related Concept Videos